180 related articles for article (PubMed ID: 18222378)
1. Significance of sentinel lymph node micrometastases in human breast cancer.
Cox CE; Kiluk JV; Riker AI; Cox JM; Allred N; Ramos DC; Dupont EL; Vrcel V; Diaz N; Boulware D
J Am Coll Surg; 2008 Feb; 206(2):261-8. PubMed ID: 18222378
[TBL] [Abstract][Full Text] [Related]
2. Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy.
Cox C; White L; Allred N; Meyers M; Dickson D; Dupont E; Cantor A; Ly Q; Dessureault S; King J; Nicosia S; Vrcel V; Diaz N
Ann Surg Oncol; 2006 May; 13(5):708-11. PubMed ID: 16538416
[TBL] [Abstract][Full Text] [Related]
3. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
Changsri C; Prakash S; Sandweiss L; Bose S
Breast J; 2004; 10(5):392-7. PubMed ID: 15327491
[TBL] [Abstract][Full Text] [Related]
4. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S
Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node.
Rivers AK; Griffith KA; Hunt KK; Degnim AC; Sabel MS; Diehl KM; Cimmino VM; Chang AE; Lucas PC; Newman LA
Ann Surg Oncol; 2006 Jan; 13(1):36-44. PubMed ID: 16378156
[TBL] [Abstract][Full Text] [Related]
6. Can sentinel lymph node biopsy be omitted in patients with favorable breast cancer histology?
Mendez JE; Fey JV; Cody H; Borgen PI; Sclafani LM
Ann Surg Oncol; 2005 Jan; 12(1):24-8. PubMed ID: 15827774
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of sentinel lymph node biopsy for the assessment of axillary status in patients with early (T1) breast carcinoma.
Gurleyik G; Aker F; Sekmen U; Saglam A
J Coll Physicians Surg Pak; 2005 Nov; 15(11):697-700. PubMed ID: 16300705
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node metastases detected by immunohistochemistry only do not mandate complete axillary lymph node dissection in breast cancer.
Gray RJ; Pockaj BA; Conley CR
Ann Surg Oncol; 2004 Dec; 11(12):1056-60. PubMed ID: 15545503
[TBL] [Abstract][Full Text] [Related]
9. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of axillary lymph node micrometastases in breast cancer.
Sakorafas GH; Geraghty J; Pavlakis G
Eur J Surg Oncol; 2004 Oct; 30(8):807-16. PubMed ID: 15336724
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with involvement of four or more axillary nodes for sentinel lymph node-positive patients.
Katz A; Niemierko A; Gage I; Evans S; Shaffer M; Smith FP; Taghian A; Magnant C
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):40-4. PubMed ID: 16488555
[TBL] [Abstract][Full Text] [Related]
12. Lymphatic tumor burden negatively impacts the ability to detect the sentinel lymph node in breast cancer.
Vargas HI; Vargas MP; Venegas R; Gonzalez KD; Burla M; Mishkin F; Khalkhali I
Am Surg; 2003 Oct; 69(10):886-90. PubMed ID: 14570368
[TBL] [Abstract][Full Text] [Related]
13. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer.
Ozmen V; Karanlik H; Cabioglu N; Igci A; Kecer M; Asoglu O; Tuzlali S; Mudun A
Breast Cancer Res Treat; 2006 Jan; 95(1):1-6. PubMed ID: 16322900
[TBL] [Abstract][Full Text] [Related]
14. Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection.
Calhoun KE; Hansen NM; Turner RR; Giuliano AE
Am J Surg; 2005 Oct; 190(4):588-91. PubMed ID: 16164927
[TBL] [Abstract][Full Text] [Related]
15. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.
Gipponi M; Canavese G; Lionetto R; Catturich A; Vecchio C; Sapino A; Friedman D; Cafiero F
Eur J Surg Oncol; 2006 Mar; 32(2):143-7. PubMed ID: 16300921
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
Chagpar A; Middleton LP; Sahin AA; Meric-Bernstam F; Kuerer HM; Feig BW; Ross MI; Ames FC; Singletary SE; Buchholz TA; Valero V; Hunt KK
Cancer; 2005 Apr; 103(8):1581-6. PubMed ID: 15747375
[TBL] [Abstract][Full Text] [Related]
17. Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer.
Derossis AM; Fey JV; Cody HS; Borgen PI
J Am Coll Surg; 2003 Dec; 197(6):896-901. PubMed ID: 14644276
[TBL] [Abstract][Full Text] [Related]
18. [Sentinel node biopsy without systematic axillary dissection: study about 1000 procedures].
Giard S; Chauvet MP; Houpeau JL; Baranzelli MC; Carpentier P; Fournier C; Belkacemi Y; Bonneterre J
Gynecol Obstet Fertil; 2005 Apr; 33(4):213-9. PubMed ID: 15894205
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer.
Katz A; Gage I; Evans S; Shaffer M; Fleury T; Smith FP; Flax R; Drogula C; Petrucci P; Magnant C
Am J Surg; 2006 Jun; 191(6):761-6. PubMed ID: 16720145
[TBL] [Abstract][Full Text] [Related]
20. Ratio of positive to total number of sentinel nodes predicts nonsentinel node status in breast cancer patients.
Tan YY; Fan YG; Lu Y; Hwang S; Ewing C; Esserman L; Morita E; Treseler P; Leong SP
Breast J; 2005; 11(4):248-53. PubMed ID: 15982390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
